[Good news] Guangdong Provincial Department of Education announced that Shenzhen Cell Valley was selected as the industrial mentor team
In accordance with the "Notice on Implementing the Vocational College Teacher Quality Improvement Plan (2021-2025)" issued by the Ministry of Education and the Ministry of Finance, as well as the "Notice on Implementing the 2025 Special Appointment Program for Industrial Mentors (Teams) in Vocational Colleges" by the Guangdong Provincial Department of Education, Shenzhen Cell Valley Team has been successfully selected as an industrial mentor team for vocational colleges in Guangdong Province through a process including self-nomination, qualification review, and expert uation.
The mentor team at Shenzhen Cell Valley comprises Professor Shi Yuanyuan (Chairman), Professor Wang Jianxun (Chief Scientist), Dr. Zhao Lijun (R&D Director), and Dr. Fu Yuchen (Chairman Assistant), collaborating closely with Professor Zhang Lijun from the School of Food and Drug Sciences at Shenzhen Polytechnic University to advance industry-education integration and talent development. Since being appointed as a vice-chair unit of Shenzhen Biomedical Industry-Education Alliance, Shenzhen Cell Valley has established deep cooperation with the university's School of Food and Drug Sciences. Guided by the principle of "government support, school-enterprise collaboration, resource sharing, and mutual benefit," both parties have implemented a comprehensive cooperation model covering textbook compilation, theoretical instruction, and practical training. This collaborative framework creates a multi-dimensional, all-encompassing, and in-depth talent education platform. Through this initiative, they aim to cultivate applied talents for innovative technologies and drive technological breakthroughs in biomedicine, providing solid support for industry advancement and industrialization. Moving forward, Shenzhen Cell Valley will prioritize building an industry mentor team and deepen partnerships with Shenzhen Polytechnic University. Leveraging its technical strengths in cell and gene therapy, the company will accelerate talent cultivation in the biopharmaceutical sector and contribute to industry progress.